Enzymatica's CEO Fredrik
Lindberg will resign after having accepted an offer from a
private pharmaceutical company that does not compete wih
Enzymatica. Fredrik Lindberg will
remain with Enzymatica until summer and act as CEO during the term
of notice. The Board of Directors will as soon as possible initiate
the recruitment for a new CEO.
STOCKHOLM, Dec. 21, 2019 /PRNewswire/ -- "Fredrik has
received an attractive offer which was difficult to resist. Since
Fredrik assumed the role as CEO of Enzymatica in 2015, the company
has evolved in an impressive way and is well positioned for a
continued international expansion. We are very grateful for
Fredrik's efforts and wish him all luck in his new position," says
Bengt Baron, Chairman of
Enzymatica.
The information in this press release is information that
Enzymatica is obliged to make public pursuant to the EU Market
Abuse Regulation. The information was submitted for publication,
through the agency of the contact person set out below, at 14.00
CET on 21 December, 2019.
For more information, please contact:
Bengt Baron, Chairman, Enzymatica
AB
Phone: +46 (0)708-59 30 09 | Email: bengt.baron@outlook.com
Carl-Johan Wachtmeister,
Communication manager Enzymatica AB
Phone: +46 (0)0701-88 50 21 | Email:
carl-johan.wachtmeister@enzymatica.com
About Enzymatica AB
Enzymatica AB is a Swedish life science company that develops
and sells health care products for primarily
conditions of the ear-nose-and-throat region. The products are
based on a barrier technology that includes marine enzymes. The
company's first product is the medical device ColdZyme®, a mouth
spray against common cold. The product has been launched in about
ten markets. The strategy is to continue to grow by developing more
health care products and strengthening the company's position in
existing markets and expanding into new geographic markets through
established partners. The company has its headquarters in
Lund and is listed on Nasdaq First
North Growth Market. For more information,
visit: www.enzymatica.com and
www.enzymatica.se/en/section/media/press-releases
Enzymatica's certified adviser is Erik Penser
Bank. Phone: +46 (0)8 463 83 00.
Email: certifiedadviser@penser.se
Enzymatica AB Ideon Science Park, SE-223 70
Lund, Sweden Telefon
+46 46-286 31 00
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/enzymatica-ab/r/enzymatica-s-ceo-resigns,c2997136